Chemotherapy in dedifferentiated chondrosarcoma: From neoadjuvant to palliative treatment options

2026/03/25 by Piotr Remiszewski, Julia Wąż, Sławomir Falkowski +3 · 1 voice
Medicine · #Bone Tumor Diagnosis and Treatments #Musculoskeletal synovial abnormalities and treatments #Sarcoma Diagnosis and Treatment

paper · doi:10.1016/j.critrevonc.2026.105297

openalex publication_date 2026/03/25 · crossref created 2026/03/25 · openalex created_date 2026/03/26 · crossref deposited 2026/05/29 · crossref indexed 2026/05/29 · crossref issued 2026/07/01 · crossref published 2026/07/01 · crossref published-print 2026/07/01 · openalex updated_date 2026/07/22

Citations

• Advanced chondrosarcomas: role of chemotherapy and survival
• International financial supervision and the evolution of a guild system: An interorganizational analysis
• Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
• Neoadjuvant or Adjuvant Chemotherapy in Soft-Tissue Sarcoma?
• Chemotherapy Strategies and Their Efficacy for Mesenchymal Chondrosarcoma

Discussions

• #BoneSarcoma #Sarcoma #Chondrosarcoma #Chemotherapy #Controversial doi.org/10.1016/j.cr... [bsky, 1 points, 0 comments]